The popularity of Sildenafil initially sparked a surge for the drug industry, but recent shifts present a complicated outlook for investors. Generic alternatives are reducing profits, and continued litigation add more https://jonasqjud923510.blog2freedom.com/41285077/sildenafil-and-big-pharma-a-risky-play